| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.05 |